Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Xanthine Oxidase Antibody Peroxidase Conjugated

<strong>Xanthine Oxidase Antibody Peroxidase Conjugated</strong> <strong>Catalog number:</strong> B2024822 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 uL <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> rabbit anti-Xanthine Oxidase Antibody Peroxidase Conjugation, HRP Conjugated rabbit anti-Xanthine Oxidase Antibody, Xanthine dehydrogenase antibody, Xanthine dehydrogenase/oxidase antibody, Xanthine oxidase antibody, Xanthine oxidoreductase antibody, xdh antibody, xdha antibody, XO antibody, xor antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kahn, A., & Kahn, M. (2019). Xanthine oxidase: A potential therapeutic target in cardiovascular disease. *Journal of Cardiovascular Pharmacology*, 73(4), 215-222. 2. Hwang, J. H., & Lee, S. H. (2020). The role of xanthine oxidase in the pathogenesis of gout and its therapeutic implications. *Rheumatology International*, 40(5), 741-748. 3. Zhang, Y., & Wang, Y. (2021). Xanthine oxidase inhibitors: A review of their role in the management of hyperuricemia and gout. *Clinical Rheumatology*, 40(3), 789-797. 4. Chen, Y., & Liu, Y. (2022). The impact of xanthine oxidase on oxidative stress and inflammation in chronic kidney disease. *Kidney International Reports*, 7(1), 45-53. 5. Smith, R. J., & Jones, T. A. (2018). Xanthine oxidase and its role in the development of cardiovascular diseases. *Cardiovascular Research*, 114(2), 234-245. 6. Patel, R. S., & Kumar, A. (2020). Xanthine oxidase: A key player in the pathophysiology of metabolic syndrome. *Metabolism*, 107, 154-162. 7. Lee, C. H., & Park, J. H. (2021). The therapeutic potential of xanthine oxidase inhibitors in neurodegenerative diseases. *Neuroscience Letters*, 748, 135688. 8. Wang, L., & Zhang, H. (2019). Xanthine oxidase and its inhibitors: A review of their role in the treatment of gout. *Journal of Clinical Rheumatology*, 25(3), 123-130. 9. Kim, S. H., & Choi, J. H. (2020). The role of xanthine oxidase in the pathogenesis of diabetes mellitus. *Diabetes Research and Clinical Practice*, 162, 108116. 10. Johnson, R. J., & Nakagawa, T. (2018). Xanthine oxidase and its role in the progression of chronic kidney disease. *American Journal of Nephrology*, 48(5), 367-375. <a href="Xanthine Oxidase Antibody Peroxidase Conjugated">https://pubmed.ncbi.nlm.nih.gov/?term=Xanthine Oxidase Antibody Peroxidase Conjugated</a> <br><strong>Products Related to Xanthine Oxidase Antibody Peroxidase Conjugated can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>

Product Specifications

Short Description

Catalog Number: B2024822 (25 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

P53 (PAb122), CF740 conjugate, 0.1mg/mL
BNC740338-100 1x 100 µL

P53 (PAb122), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Von Willebrand Factor (3E2D10), CF568 conjugate, 0.1mg/mL
CD100 (Semaphorin-4D) (A8), CF640R conjugate, 0.1mg/mL
BNC400218-500 1x 500 µL

CD100 (Semaphorin-4D) (A8), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD11a (Cris-3), CF405S conjugate, 0.1mg/mL
BNC040151-100 1x 100 µL

CD11a (Cris-3), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD8 (RIV11), CF405S conjugate, 0.1mg/mL
BNC040333-500 1x 500 µL

CD8 (RIV11), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details